Synthetic Parasites: A Successful Mucosal Nanoparticle Vaccine Against Toxoplasma Congenital Infection in Mice
Author(s) -
Céline Ducournau,
Thi Thanh Loi Nguyen,
Rodolphe Carpentier,
Isabelle Lantier,
Stéphanie Germon,
F. Précausta,
PierreJean Pisella,
Hervé Leroux,
Nathalie van Langendonck,
Didier Betbeder,
Isabelle DimierPoisson
Publication year - 2017
Publication title -
future microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.797
H-Index - 82
eISSN - 1746-0921
pISSN - 1746-0913
DOI - 10.2217/fmb-2016-0146
Subject(s) - immune system , nasal administration , immunology , toxoplasmosis , congenital toxoplasmosis , pregnancy , toxoplasma gondii , pathogen , biology , inflammation , immunization , medicine , virology , antibody , genetics
Development of protein vaccine to prevent congenital infection is a major public health priority. Our goal is the design of mucosal synthetic pathogen inducing protective immune responses against congenital toxoplasmosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom